info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Diabetes Market Analysis

ID: MRFR//2180-HCR | 60 Pages | Author: Kinjoll Dey| November 2024

The market for diabetic products in India is always changing because a lot of different things are affecting it. In this way, chances and problems are both made.
In India, a lot more people now have diabetes than before. This could be mostly because of changes in culture, like more people living in cities, and a natural way of being more likely to get the disease.
India's strict rules are a big part of why the diabetes business there has grown so quickly. It's hard for companies to get into the market, set prices, and follow healthcare laws because of strict rules about drugs that can be sold and following healthcare laws. These rules also affect how the industry grows as a whole.
The diabetes market is changing because of new health care tools, like insulin delivery systems and gadgets that check glucose. Our success not only helps other people do better, but it also makes room for the market to grow.
As we learn more about how to treat and avoid diabetes, people who have it change the way they act. Market trends are being changed by people who are investigating and planning ahead. This is because health and well-being are becoming more important.
The diabetes market is greatly affected by things like how much money people make and how easy it is for them to get medical care. People with different amounts of money can't get the same diabetes care products and services. Because of this, strategies for pricing and dividing the market need to be carefully considered.
The way the market works has changed because of what the Indian government has done to fight diabetes. This is why it's getting more and more important to have programs that teach people about diabetes, offer tests, and provide cheap treatment choices. These programs should make the diabetes community better and easier to join.
These days, tech companies, health care services, and drug companies work together on projects more often. By sharing what they know, these companies hope to find complete cures for diabetes. This will finally help the market grow.
Indian culture and food habits have a big impact on how they treat people with diabetes. A big thing that changes the way the market works is the need for food, vitamins, and changes in living that are good for people with diabetes.
The Indian drugstore business sells a lot of fake drugs, which has a big impact on price changes. When generic forms of diabetes drugs come out, they help bring down the price of these drugs and also make drug companies fight more.
The way people with diabetes are cared for is changing because of telemedicine and digital health tools. Service like online tracking, virtual calls, and digital tools for health management are changing the way standard markets work as more and more people use them.
Even though a lot of success has been made, there are still issues with the services and going to health care, especially in outside cities. To make sure that people with diabetes get fair things and services, this issue needs to be fixed right away.
The Indian market for diabetes is going to grow a lot over the next few years. This is because rules about school, technology, and health care are always changing. A lot of people believe that natural health care, personalized treatment, and tests run by AI will have an effect on the future of the business.

India Diabetes Market Overview


The India diabetes market size was valued at USD 6.75 Billion in 2023 and is projected to grow from USD 6.86 Billion in 2024 to USD 11.46 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.54% during the forecast period (2024 - 2032). Diabetes is a chronic metabolic condition that results in high blood glucose levels, which seriously harms the heart, blood vessels, eyes, kidneys, and nerves. Drugs used to treat diabetes are known as diabetic therapies, which consist of oral diabetes medications and human insulin mimics.


India Diabetes Market


India Diabetes Market Trends


The leading causes of diabetes mellitus in Indians are obesity, particularly central obesity, increased visceral fat brought on by physical inactivity, and diets high in calories, fat, and sugar. The most prevalent work culture that is still practised in the nation, which involves consuming fast food while engaging in little to no physical exercise and spending hours in one position while seated, is a major factor in the rapid rise in diabetes incidence among India's working-age population. Additionally, the rising number of diabetic people and its growing prevalence and expanding use of insulin-delivery and continuous glucose monitoring devices are propelling market expansion. In India, 77 million people were estimated to have diabetes in 2019, and by 2045, that number is expected to reach over 134 million. About 57% of these people are still undiagnosed. However, problems faced by poor individuals across India in managing diabetes care are major restraining factors for the market.


India Diabetes Market Segment Insights 


The said market segment has been segmented based on type which comprises Type 1, Type 2, and Gestational diabetes.


Based on tests, the market is segmented into Random blood sugar tests, Fasting blood sugar tests, Oral glucose tolerance tests, Initial glucose challenge tests and others.


Based on devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others.


Based on treatment, the market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and Blood Sugar Treatment.


India Diabetes Regional Insights 


Considering the scenario of the Indian diabetes market, the western region is believed to be the largest market share holder for diabetes care. Moreover, the Eastern and Northern regions are also growing and the second-largest market for India's Diabetes treatment sector. On the other hand, the Southern Indian market is expected to grow at a significant rate in the Indian diabetes market during the forecasted period. The central region is likely to have limited but moderate growth in the said market segment.


India Diabetes Market Key Players Insights



  • Novo Nordisk A/S (Denmark)

  • USV Private Limited (India)

  • sanofi-aventis U.S

  • LLC (US)

  • Novartis AG (Switzerland)

  • Merck & Co., Inc. (US)

  • Becton Dickinson and Company (US)

  • Roche Diabetes Care, Inc.(US),

  • Johnson & Johnson Services, Inc.(us)

  • Bayer AG (Germany)

  • Ypsomed (Switzerland)


The report for India Diabetes Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Recent Developments in India Diabetes Market 


February 2024:In February 2024, Roche Diabetes Care Launched a new continuous glucose monitoring (CGM) system in India, aiming to improve diabetes management and glycemic control.



Study objectives of India Diabetes Market


  • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Indian Diabetes Market

  • To provide insights about factors affecting the market growth

  • To analyze the India Diabetes Market based on various factors - price analysis, supply chain analysis, Porters Five Forces analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments

  • To provide detailed analysis of the market with respect to the current market size and future prospective

  • To provide detailed analysis of the market for segments by type, by test, by devices, by treatment, and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Market



 Intended Audience




  • Hospitals and Clinics

  • Diabetes drugs and devices manufacturers

  • Diabetes drugs and devices suppliers

  • Government and Independent Regulatory Authorities

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Potential Investors



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.